Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Sponsor : Apple Tree Partners
Deal Size : $75.0 million
Deal Type : Series A Financing
Details : The financing will be used for the development of medicines that block notoriously difficult-to-drug protein targets with a new mode of action, selective termination of protein synthesis (STOPS) by using Initial's proprietary STOPS platform.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
May 01, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Sponsor : Apple Tree Partners
Deal Size : $75.0 million
Deal Type : Series A Financing
Reset All
